COVID-19 Resources for Blood Donor Centers
Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
Switzerland to Remove Donor Deferrals Related to vCJD Risk
January 14, 2026
FDA Announces More Flexible Approach to CGT Regulation
January 13, 2026
REGULATORY UPDATE: FDA Releases 2026 CBER Guidance Agenda
January 12, 2026